Oncology Institute (DFPH) Receivables - Net (2020 - 2026)

Oncology Institute (DFPH) has 7 years of Receivables - Net data on file, last reported at $58.1 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net rose 17.87% year-over-year to $58.1 million; the trailing twelve-month figure through Mar 2026 stood at $58.1 million (up 17.87% YoY), and the FY2025 full-year result was $59.0 million, up 22.06% from the prior year.
• Receivables - Net for Q1 2026 stood at $58.1 million, down from $59.0 million in the prior quarter.
• Across five years, Receivables - Net topped out at $59.6 million in Q3 2025 and bottomed at $24.5 million in Q1 2022.
• The 5-year median for Receivables - Net is $48.4 million (2023), against an average of $47.6 million.
• The widest annual swing landed in 2022, when Receivables - Net jumped 99.01%; it then fell 16.07% in 2025.
• A 5-year view of Receivables - Net shows it stood at $39.8 million in 2022, then gained by 6.39% to $42.4 million in 2023, then increased by 14.11% to $48.3 million in 2024, then climbed by 22.06% to $59.0 million in 2025, then decreased by 1.46% to $58.1 million in 2026.
• The last three Receivables - Net figures came in at $58.1 million (Q1 2026), $59.0 million (Q4 2025), and $59.6 million (Q3 2025), per Business Quant data.

Peer Comparison